Martina Tuttolomondo

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Carla L. Alves, Sidse Ehmsen, Mikkel G. Terp et al. · Nature Communications · 2021 · 77 citations · Full text

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer

Abeer J. Al-Qasem, Carla L. Alves, Sidse Ehmsen et al. · npj Precision Oncology · 2022 · 67 citations · Full text

Breast Oncology, Chemoprevention Strategy, Cancer Biology +16

Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery

Martina Tuttolomondo, Cinzia Casella, Pernille Lund Hansen et al. · Molecular Therapy — Nucleic Acids · 2017 · 40 citations · Full text

Macrophage CD5L is a target for cancer immunotherapy

Lidia Sánchez-Moral, Tony Paul, Clara Martori et al. · EBioMedicine · 2023 · 24 citations · Full text

A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication

Martina Tuttolomondo, Stephanie Thuy Duong Pham, Mikkel G. Terp et al. · Molecular Therapy — Nucleic Acids · 2024 · 11 citations · Full text